Market Tracker

03/23 6:13am ET

Abbott Laboratories (NYSE:ABT)

44.81
Delayed Data
As of Mar 22
 +0.01 / +0.02%
Today’s Change
36.76
Today|||52-Week Range
45.84
+16.66%
Year-to-Date
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
Abbott Labs Is Set to Go Substantially Higher
Mar 20 / TheStreet.com - Paid Partner Content
Can Abbott Outperform Despite Alere?
Mar 22 / TheStreet.com - Paid Partner Content
Global Stocks, US Futures Slide Spooked By G20 Protectionist Shift; Dollar Drops For ...
Mar 20 / Investing Channel - Paid Partner Content
Joel Greenblatt Raises Holdings of CVS Health, Priceline, HP
Mar 21 / GuruFocus News - Paid Partner Content
Mairs & Power Growth Fund 4th Quarter Commentary
Mar 16 / GuruFocus News - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Alere Delays Filing for 2nd Year in a Row
Mar 16 / GuruFocus News - Paid Partner Content
Abbott Laboratories' MitraClip Outcome Positive for DMR
Mar 20 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close44.80
Today’s open44.94
Day’s range44.59 - 45.07
Volume5,198,940
Average volume (3 months)8,834,823
Market cap$77.4B
Dividend yield2.37%
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+11.38%
Earnings growth (next 5 years)+10.65%
Revenue growth (last year)+2.20%
P/E ratio63.1
Price/Sales2.73
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.61+2.01%
AGNAllergan-0.56-0.24%
NVONovo Nordisk+0.22+0.65%
LLYEli Lilly and Co+0.63+0.75%
Data as of 03/22/2017

Financials

Next reporting dateApril 19, 2017
EPS forecast (this quarter)$0.43
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts